View Live Stream
The webcast link will be available here 15 minutes before the start of the live webcast.
Sign In for Credit
Get Notified before the Start Time
Follow this event to receive an email or SMS reminder before the event.
Visit your profile to choose your preferred contact method.
This Pediatric Hematology-Oncology Problem Case Conference will take place on Tuesday, November 30, 2021 at 4:00 P.M. Live attendance for this conference will only be available through Zoom.
Pediatric hematology/oncology, radiation oncology, pediatric surgery, and radiology physicians, residents, fellows and medical students need to be regularly updated on advances in the diagnosis and management of patients with hematologic disorders and malignancies. The series aims to broaden the knowledge base of learners in these topic areas and improve their competencies to enhance the patient care experience and outcomes.
At the conclusion of the session, the participants should be able to:
- Describe typical and atypical presentations of acute and subacute methotrexate neurotoxicity.
- Describe common treatments for methotrexate neurotoxicity and the supporting evidence and rationale behind their use.
- Outline the effects of methotrexate on future neurocognitive outcomes in long-term cancer survivors treated with this chemotherapeutic agent.
- Medical Students
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Baylor College of Medicine
The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial SupportSM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: 1) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.
Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.
If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Baylor College of Medicine
Nothing to disclose.
Planning Committee Members
CME Credit Available
You may claim CME credit after watching this activity.
Pediatric Hematology-Oncology Fellow Baylor College of Medicine